Catalyst Pharma (CPRX) Shares Jump 20% as CPP-115 Safe, Well Tolerated Across All Doses
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Join SI Premium – FREE
Shares of Catalyst Pharma (Nasdaq: CPRX) are up nearly 20 percent in Tuesday's pre-market session following news the company's CPP-115 candidate is both safe and well tolerated across all dose ranges. After closing Monday at $0.80, the stock is now trading around $0.96.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New PFA survey is most positive for this MedTech stock
- Shares in this major AI chipmakers are "inexpensive": Barclays
- Piper remains bullish on this beverage stock, citing 'best-in-class execution'
Create E-mail Alert Related Categories
Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
